Long-term followup needed to define role of infliximab in treatment of renal amyloidosis: Comment on the case report by Elkayam et al [4]

Nurit Tweezer-Zaks*, Pnina Langevitz, Avi Livneh

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)3298-3299
Number of pages2
JournalArthritis and Rheumatism
Issue number11
StatePublished - Nov 2003
Externally publishedYes

Cite this